Hood River Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Hood River Capital Management LLC

  • $5.4 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$28.0 - $40.56 $45,668 - $66,153
1,631 Added 0.44%
373,254 $15.1 Million
Q3 2022

Nov 14, 2022
BUY
$29.63 - $48.31 $244,269 - $398,267
8,244 Added 2.27%
371,623 $12.3 Million
Q2 2022

Aug 15, 2022
BUY
$27.79 - $50.61 $508,390 - $925,859
18,294 Added 5.3%
363,379 $12.8 Million
Q1 2022

May 16, 2022
BUY
$39.62 - $69.97 $273,932 - $483,772
6,914 Added 2.04%
345,085 $15.9 Million
Q4 2021

Feb 14, 2022
SELL
$58.09 - $82.51 $32,704 - $46,453
-563 Reduced 0.17%
338,171 $22.4 Million
Q3 2021

Nov 15, 2021
SELL
$58.38 - $84.96 $779,664 - $1.13 Million
-13,355 Reduced 3.79%
338,734 $21.1 Million
Q2 2021

Aug 13, 2021
SELL
$62.15 - $90.32 $310,314 - $450,967
-4,993 Reduced 1.4%
352,089 $29.2 Million
Q1 2021

May 17, 2021
SELL
$61.35 - $90.47 $2.22 Million - $3.27 Million
-36,181 Reduced 9.2%
357,082 $23.7 Million
Q4 2020

Feb 16, 2021
BUY
$43.82 - $85.37 $350,735 - $683,301
8,004 Added 2.08%
393,263 $30.2 Million
Q3 2020

Nov 16, 2020
SELL
$33.21 - $51.27 $1.29 Million - $1.99 Million
-38,869 Reduced 9.16%
385,259 $16.6 Million
Q2 2020

Aug 14, 2020
BUY
$26.12 - $43.27 $11.1 Million - $18.4 Million
424,128 New
424,128 $18.3 Million

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.01B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email